JP2002541067A - 腫瘍マーカーｍｕｃ１のペプチド変異体及びその利用 - Google Patents

腫瘍マーカーｍｕｃ１のペプチド変異体及びその利用

Info

Publication number
JP2002541067A
JP2002541067A JP2000599782A JP2000599782A JP2002541067A JP 2002541067 A JP2002541067 A JP 2002541067A JP 2000599782 A JP2000599782 A JP 2000599782A JP 2000599782 A JP2000599782 A JP 2000599782A JP 2002541067 A JP2002541067 A JP 2002541067A
Authority
JP
Japan
Prior art keywords
peptide
sequence
muc1
vntr
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000599782A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002541067A5 (enExample
Inventor
ハニシュ，フランツ−ゲオルク
ミュラー，ステファン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JP2002541067A publication Critical patent/JP2002541067A/ja
Publication of JP2002541067A5 publication Critical patent/JP2002541067A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2000599782A 1999-02-17 2000-02-17 腫瘍マーカーｍｕｃ１のペプチド変異体及びその利用 Pending JP2002541067A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19906615.9 1999-02-17
DE19906615A DE19906615A1 (de) 1999-02-17 1999-02-17 Peptid-Varianten des Tumormarkers MUC1 und ihre Verwendung
PCT/DE2000/000440 WO2000049045A1 (de) 1999-02-17 2000-02-17 Peptid-varianten des tumormarkers muc1 und ihre verwendung

Publications (2)

Publication Number Publication Date
JP2002541067A true JP2002541067A (ja) 2002-12-03
JP2002541067A5 JP2002541067A5 (enExample) 2007-03-15

Family

ID=7897778

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000599782A Pending JP2002541067A (ja) 1999-02-17 2000-02-17 腫瘍マーカーｍｕｃ１のペプチド変異体及びその利用

Country Status (10)

Country Link
US (1) US20090054622A1 (enExample)
EP (1) EP1151005B1 (enExample)
JP (1) JP2002541067A (enExample)
AT (1) ATE243222T1 (enExample)
AU (1) AU772709B2 (enExample)
CA (1) CA2368309A1 (enExample)
DE (2) DE19906615A1 (enExample)
DK (1) DK1151005T3 (enExample)
ES (1) ES2200851T3 (enExample)
WO (1) WO2000049045A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003266236A1 (en) 2002-07-22 2004-02-09 Nemod Immuntherapie Ag Method for the production of an immunostimulating mucin (muc1)
US9346867B2 (en) 2010-04-19 2016-05-24 Sumitomo Bakelite Co., Ltd. Cancer-related glycopeptide epitopes, antibodies and methods of use
KR102049928B1 (ko) 2011-08-17 2019-11-28 글로브이뮨 효모-muc1 면역요법 조성물 및 그 용도

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3023469B2 (ja) * 1992-02-21 2000-03-21 株式会社日本抗体研究所 糖タンパク質３９遺伝子
US6120765A (en) * 1993-04-02 2000-09-19 Shiseido Co. Ltd. Urokinase plasminogen activator fragments
US5744144A (en) * 1993-07-30 1998-04-28 University Of Pittsburgh University Patent Committee Policy And Procedures Synthetic multiple tandem repeat mucin and mucin-like peptides, and uses thereof
AU727308B2 (en) * 1997-02-24 2000-12-07 Dana-Farber Cancer Institute Recombinant pox virus for immunization against muc1 tumor-associated antigen

Also Published As

Publication number Publication date
DK1151005T3 (da) 2003-10-13
ATE243222T1 (de) 2003-07-15
DE50002584D1 (de) 2003-07-24
CA2368309A1 (en) 2000-08-24
AU772709B2 (en) 2004-05-06
EP1151005A1 (de) 2001-11-07
ES2200851T3 (es) 2004-03-16
AU3801300A (en) 2000-09-04
US20090054622A1 (en) 2009-02-26
DE19906615A1 (de) 2000-09-28
EP1151005B1 (de) 2003-06-18
WO2000049045A1 (de) 2000-08-24

Similar Documents

Publication Publication Date Title
Rydlander et al. Molecular characterization of a tissue‐polypeptide‐specific‐antigen epitope and its relationship to human cytokeratin 18
AU2007202776B2 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
EP0804231B1 (en) Synthetic multiple tandem repeat mucin and mucin-like peptides, and uses thereof
Timpte et al. Porcine submaxillary gland apomucin contains tandemly repeated, identical sequences of 81 residues.
US6677428B1 (en) Mammaglobin, a secreted mammary-specific breast cancer protein
US7202334B1 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
CN1714150B (zh) 肿瘤内差异表达的基因产物及其应用
Sun et al. Transcript map of the 8p23 putative tumor suppressor region
AU735338B2 (en) Mammaglobin, a secreted mammary-specific breast cancer protein
KR19990087802A (ko) 전립선암의 면역치료 및 면역진단을 위한 화합물 및 방법
WO2008035350A1 (en) Antigen specific multi epitope vaccines
JP2001524810A (ja) 新規な前立腺関連カリクレイン
AU2020200990A1 (en) Identification of MHC class I phospho-peptide antigens from breast cancer utilizing SHLA technology and complementary enrichment strategies
JP2002533082A (ja) 結腸癌の免疫療法および診断のための化合物およびそれらの使用のための方法
KR101261887B1 (ko) 종양에서 특이적으로 발현되는 유전자 산물 및 이의 용도
JP2001515720A (ja) β−デフェンシン
JP2003514543A (ja) ２３個のヒト分泌タンパク質
JP2002541067A (ja) 腫瘍マーカーｍｕｃ１のペプチド変異体及びその利用
JP4190291B2 (ja) 癌細胞の増殖を調節するのに有用なポリヌクレオチド
JP2001527408A (ja) Ｓｓｘファミリーのメンバーをコードする単離核酸分子、およびそれらの利用方法
JP3457004B6 (ja) ｈＰＴＨ（１−３７）配列由来のペプチド
JP3799180B2 (ja) ブタ血清レクチン遺伝子
US20030170246A1 (en) Lipophilin complexes for use in cancer diagnosis and therapy
JP2004526406A (ja) 卵巣癌の治療および診断のための組成物および方法
HK1044021A1 (zh) 用於治療和診斷卵巢癌的組合物和方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070125

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070125

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20081212

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20081212

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090908

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100216